| __timestamp | Corcept Therapeutics Incorporated | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 882000 | 9216000000 |
| Thursday, January 1, 2015 | 1361000 | 8296000000 |
| Friday, January 1, 2016 | 2058000 | 10044000000 |
| Sunday, January 1, 2017 | 3554000 | 11560000000 |
| Monday, January 1, 2018 | 5215000 | 10558000000 |
| Tuesday, January 1, 2019 | 5504000 | 9351000000 |
| Wednesday, January 1, 2020 | 5582000 | 8933000000 |
| Friday, January 1, 2021 | 5281000 | 8284000000 |
| Saturday, January 1, 2022 | 5385000 | 7952000000 |
| Sunday, January 1, 2023 | 6481000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding the cost of revenue is crucial for assessing a company's financial health. This analysis focuses on Teva Pharmaceutical Industries Limited and Corcept Therapeutics Incorporated, two prominent players in the field. Over the past decade, Teva's cost of revenue has shown a downward trend, decreasing by approximately 13% from 2014 to 2023. In contrast, Corcept Therapeutics has experienced a significant increase, with costs rising by over 600% during the same period. This divergence highlights the contrasting strategies and market dynamics faced by these companies. Teva, a global leader, has been optimizing its operations, while Corcept, a niche player, is expanding its market presence. These insights provide a window into the strategic decisions shaping the pharmaceutical landscape today.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Cost of Revenue Comparison: Gilead Sciences, Inc. vs Corcept Therapeutics Incorporated
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Corcept Therapeutics Incorporated
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Veracyte, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for BeiGene, Ltd. and Corcept Therapeutics Incorporated
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and Corcept Therapeutics Incorporated's Expenses
Cost Insights: Breaking Down Pharming Group N.V. and Corcept Therapeutics Incorporated's Expenses
Cost of Revenue: Key Insights for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated vs HUTCHMED (China) Limited: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Corcept Therapeutics Incorporated and Celldex Therapeutics, Inc.'s Expenses